Journal: Blood
Article Title: MicroRNA-130a-mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors.
doi: 10.1182/blood-2011-03-339978
Figure Lengend Snippet: Figure 3. Biologic effect of increased miR-130a expression. Stable transfection of 32Dcl3 cells with the pEGP-miR-130a, pEGP-miR-223, or pEGP-miR-Null vectors was performed, generating 3 pEGP-miR-130a (Cl 3, Cl 6, and Cl 7) clones, 1 pEGP-miR223 (miR-223) clone, and 1 pEGP-miR-null (null) clone. (A) Relative miR-130a expression in Cl 3, Cl 6, Cl 7, null, and miR-223 was determined by real-time PCR and normalized to Sno234 expression. (B) Relative miR-223 expres- sion in clone miR-223 and null was determined by real-time PCR and normalized to Sno234 expression. (C) Immunoblot showing Smad4 protein expression in the Cl 3, Cl 6, Cl 7, null, and miR-223 clones. The graph shows the relative expression of Smad4 protein relative to the expression of -actin. The highest value among those being compared was assigned the value 1, and the remaining values were recalculated accordingly. (D) The relative expression level of Smad4 mRNA in the Cl 3, Cl 6, Cl 7, null, and miR-223 clones was measured by real-time PCR and normalized to -actin expression. Data are shown as the mean SD from triplicate measurements. (E) Cell proliferation assays were performed with the clones Cl 3, Cl 6, Cl 7, null, and miR-223 in the presence or absence of human recombinant TGF-1 (20nM). The graph shows the relative number of cells after 4 days when TGF-1– stimulated cells are compared with unstimulated cells for each clone. The mean reduction in cell number (Red. in cell no.) for TGF-1–stimulated cells for each clone was 8% for Cl 3, 31% for Cl 6, 8% for Cl 7, 43% for null, and 52% for miR-223 (the values are based on 3 independent growth experiments). The cell number for the unstimulated cells was assigned the value 1, and the relative number of TGF-1–
Article Snippet: 32Dcl3 cells (ATCC CRL-11 346) were cultured in RPMI 1640 medium (Invitrogen), 10% non–heat-inactivated FBS (Gibco BRL), 1% P/S, and 1 ng/mL murine IL-3 (Sigma-Aldrich).
Techniques: Expressing, Stable Transfection, Clone Assay, Real-time Polymerase Chain Reaction, Western Blot, Recombinant